Cargando…
Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19
BACKGROUND: The rate and composition of bacterial co-infection in patients with coronavirus disease 2019 (COVID-19) were evaluated when microbiological testing was conducted on the majority of patients. We also evaluated whether the use of empirical antibacterials was associated with mortality. METH...
Autores principales: | Lee, Jiyoung, Chang, Euijin, Jung, Jiwon, Kim, Min Jae, Chong, Yong Pil, Kim, Sung-Han, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Bae, Seongman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886529/ https://www.ncbi.nlm.nih.gov/pubmed/36718563 http://dx.doi.org/10.3346/jkms.2023.38.e37 |
Ejemplares similares
-
785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2022) -
Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study
por: Han, Jaijun, et al.
Publicado: (2023) -
Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023) -
Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023) -
Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)